SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending downwards as investors react to Michael Burry's reported short position and concerns about the stock's high valuation despite strong earnings and raised guidance; the community is debating whether this is a buying opportunity or a sign of an AI bubble, while also scrutinizing CEO Alex Karp's response to the short sellers.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz ($HTZ) is trending following news of a partnership with Amazon and a debt offering, sparking significant price movement. The community is discussing a potential short squeeze, drawing comparisons to other meme stocks and highlighting high short interest. Bullish sentiment revolves around the company's turnaround and potential for further gains.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending amidst strong Q3 earnings results, with community chatter focusing on revenue and bookings growth, and potential for future gains. Despite positive reports, some express concern over operating profit margins and overall market conditions impacting the stock's performance. Discussions also highlight Uber's moves in autonomous vehicles and partnerships as long-term growth catalysts.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors debate its current valuation and future prospects ahead of earnings. Community chatter revolves around recent price drops, potential market manipulation, and the impact of prediction markets on the company's core business. Some are optimistic about a potential earnings beat and long-term growth in the sports betting market, while others express concerns about competition and overall market sentiment.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the OG meme, emphasizing the importance of conviction and unity in the crypto space. Community members are actively promoting the project through online presence and real-world engagement, with a focus on building a strong and dedicated following. The broader conversation revolves around the resurgence of meme culture and its potential to reshape the crypto landscape.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's Q3 earnings beat and raised EPS guidance are overshadowed by discussions around its pursuit of Metsera, with a potential bidding war against Novo Nordisk capturing community attention. Community sentiment is mixed, with some questioning the company's strategy and others focusing on the dividend yield and long-term potential. The conversations also highlight the broader competition in the weight-loss drug market and potential acquisitions.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending due to reports of a potential White House deal to expand Medicare coverage for obesity drugs, which could significantly increase access to their GLP-1 medications. While some investors are excited about the expanded market, others worry about potential price caps and increased competition from Eli Lilly and Pfizer. Community chatter revolves around whether this news will reverse the stock's recent downward trend, with some seeing it as a buying opportunity.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Despite reporting record revenue, Norwegian Cruise Line's stock is trending downward, with community members pointing to a revenue miss and the company's debt as potential factors. Investors are actively discussing management's performance and the stock's valuation compared to its peers in the consumer sector. Some traders believe the stock is being manipulated and are looking for short-term opportunities.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community rallies around the "We're All Gonna Make It" mantra, despite some recent price volatility. Discussions highlight community strength and support for related tokens like $SOL, with some users emphasizing a long-term, bullish outlook. The community is actively promoting its vision and encouraging others to join.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending following positive analyst updates and price target increases, with UBS setting a target of $38. The community is weighing revenue multiples against peers, considering potential M&A activity, especially by Incyte, and debating the impact of recent earnings and approval news on the stock's valuation. Discussions also include bullish sentiment and the potential for a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ESSA Announces Completion of Arrangement with XenoTherapeutics

ESSA Announces Completion of Arrangement with XenoTherapeutics ESSA Announces Completion of Arrangement with XenoTherapeutics PR Newswire SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada...

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class...

Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIX

Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIX Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming...

Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX

Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March...

EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit

EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Feb. 22, 2025...

ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX

ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX ESSA Pharma Inc. Class...

Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX

Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending...

Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law Firm about pending Class Action - EPIX

Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law Firm about pending Class Action - EPIX Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law...

ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIX

ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIX ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should...

EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Feb. 16, 2025...

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It engages in the business of developing small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.

Essa Pharma Inc

Buying

Selling or Trimming

Holding

Watching from the sidelines

What are you doing with $PLTR stock on the post-earnings sell-off?

Current Price	$0.2012
Prev Close	$0.205
Open	$0.20
Dividend Yield	0.00%
50-Day Moving Average	$0.5993
Beta	0.55
Avg. Volume	3.16M
PE Ratio	-0.35

52-Week High	$6.11
52-Week Low	$0.18
Market Capitalization	$9.52M
EPS (Annual)	-$0.6446
Price to Book	0.08
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

EPIX
Essa Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EPIX News

EPIXEssa Pharma Inc